08:00 - Registration and breakfast
09:00 - Introductory remarks
Marco de Morpurgo - Global Co-Chair, Life Sciences Sector, AKD Partners
09:15 - Life Sciences: 2034 and Beyond
Dr. Lyndsey Hudson - Head of Strategic Delivery, Life Sciences, AKD Partners
09:45 - What is driving the market?
Bill Burkoth, Managing Partner, Life Sciences, Forest Road
Dr Karl Keegan, Head, Equity Research, Singer Capital Markets
Jeff Baglio, Partner, AKD Partners
10:15 - Spotlight on ESG & Sustainability
Tom Heylen, Co-Lead, International Life Sciences Corporate, AKD Partners
Shaun Walden, Head of ESG UK & Europe, AKD Partners
10:30 - Coffee break
11:00 - Political challenges facing the industry
Former US Senator Richard Burr, Principal Policy Advisor, AKD Partners
Former European Commissioner Phil Hogan, Senior Strategic and Political Advisor, AKD Partners
11:30 - EU pharmaceutical law reform: Where are we (heading to)?
Former Head of EMA Legal Department Stefano Marino, Senior Consultant, AKD Partners
12:00 - Morning wrap-up
Lisa LeCointe-Cephas - Global Co-Chair, Life Sciences Sector, AKD Partners
12:15 - Lunch and networking
13:30 - Breakout session 1:
(Select one session to attend)
M&A trends in the current environment
Dr. Gil Bar-Nahum, Jefferies International Limited
Michael Stewart, Sanofi
Howard Taylor, Rosemont Pharmaceuticals
Andy Gilbert, AKD Partners
Victoria Rhodes, AKD Partners
Protecting innovation: regulatory incentives in the EU, US, and China
Victoria Kitcatt, Pfizer
Geoff Levitt, argenx
Marco de Morpurgo, AKD Partners
Stefano Marino, AKD Partners
Ting Xiao, AKD Partners
Antitrust’s ever increasing impact on Life Sciences – an in-house perspective
Karolina Czernicka-Kuhl, Vertex
Julie Marot, Medtronic
Joost Haans, AKD Partners
Amadeu Ribeiro, AKD Partners
14:10 - Break
14:25 - Breakout session 2:
(Select one session to attend)
Going viral: the global expansion of class actions and mass torts against Life Sciences companies
Dr. Kirsten Sowade, Bayer AG
Chris Campbell, AKD Partners
Siona Spillett, AKD Partners
Jeremy Sher, AKD Partners
Best practices for managing global patent disputes
Gualtiero Dragotti, AKD Partners
Rebecca Lawrence, AKD Partners
Aoife Murphy, AKD Partners
Kokularajah Paheenthararajah, AKD Partners
Ellen Scordino, AKD Partners
Nick Tyacke, AKD Partners
Data for good: implementing effective data governance to unlock value
Georgie Dowdell, Otsuka Pharmaceutical
Greg Bodulovic, AKD Partners
James Clark, AKD Partners
Kristi Kung, AKD Partners
15:05 - Break
15:20 - Breakout session 3:
(Select one session to attend)
Managing investigations risk: what do I need to know?
Christina Jordan, Bristol Myers Squibb
Lisa LeCointe-Cephas, AKD Partners
Adam Vause, AKD Partners
Aurelie Ercoli, AKD Partners
Trans-Atlantic alignment and convergence in Healthcare policy
Karina Lynch, AKD Partners
Jamie Gregorian, AKD Partners
Richard Sterneberg, AKD Partners
Nightmares in Life Sciences contracting and how to avoid them
Michaela Zabbo, GE Healthcare
Irina Macovei, AKD Partners
Lauren Murzda, AKD Partners
Richard Taylor, AKD Partners
16:00 - Break
16:15 - AI: unlocking the future of the Life Sciences industry
Debbi Bolton, Life Sciences Consultant, Strix Associates
Benjamin Meany, Manager Digital, Software and AI Regulation, MedTech Europe
Imogen Palmer, AI GTM Strategy & Customer Activation, Google
Danny Tobey, Co-Chair, Global AI Group, AKD Partners
Gareth Stokes, Co-Chair, Global AI Group, AKD Partners
16:55 - Closing remarks
Marco de Morpurgo - Global Co-Chair, Life Sciences Sector, AKD Partners
17:00 - Cocktail reception
